Amyloidosis other imaging findings

Jump to navigation Jump to search

Amyloidosis Microchapters


Patient Information


Historical Perspective


Primary amyloidosis
Secondary amyloidosis
Familial amyloidosis
Wild-type (senile) amyloidosis
Cardiac amyloidosis
Beta-2 microglobulin related amyloidosis
Gelsolin related amyloidosis
Lysozyme amyloid related amyloidosis
Leucocyte cell-derived chemotaxin 2 related amyloidosis
Fibrinogen A alpha-chain associated amyloidosis



Differentiating Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound

CT scan


Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Amyloidosis other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Amyloidosis other imaging findings

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Amyloidosis other imaging findings

CDC on Amyloidosis other imaging findings

Amyloidosis other imaging findings in the news

Blogs on Amyloidosis other imaging findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Amyloidosis other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]


Tissue doppler echocardiography and myocardial strain rate imaging has been shown to be very sensitive for the assessment of myocardial dysfunction in restrictive cardiomyopathy. The developmend of serum amyloid P component (SAP) scans has given physicians the ability to specifically locate amyloid deposits.

Other Imaging Findings

  • In addition, all amyloid deposits contain serum amyloid P component (SAP), a circulating protein of the pentraxin family. Radionuclide SAP scans have been developed which can anatomically localize amyloid deposits in patients.[1]
  • Tissue doppler and myocardial strain rate imaging has been proven to be very sensitive for the assessment of myocardial dysfunction in restrictive cardiomyopathy. Doppler studies may show abnormal wall motion early in the disease process.
  • Abdominal ultrasound may reveal a swollen liver or spleen.
  • Thyroid ultrasound can help diagnose thyroidal involvement by amyloidosis.


  1. Pepys MB, Gallimore JR, Lloyd J, Li Z, Graham D, Taylor GW; et al. (2012). "Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use". J Immunol Methods. 384 (1–2): 92–102. doi:10.1016/j.jim.2012.07.013. PMC 4068106. PMID 22867744.

Template:WH Template:WS